In a research note made public on Monday, 13 February, Evgen Pharma Plc (LON:EVG) stock had its Buy Rating reiterated by research professionals at Northland Capital. They currently have a GBX 97.00 TP on company. Northland Capital’s target gives a potential upside of 397.44% from the company’s current stock price.
Among 19 analysts covering Panera Bread (NASDAQ:PNRA), 15 have Buy rating, 1 Sell and 3 Hold. Therefore 79% are positive. Panera Bread had 32 analyst reports since July 30, 2015 according to SRatingsIntel. The rating was maintained by Telsey Advisory Group with “Outperform” on Monday, May 2. The rating was maintained by RBC Capital Markets with “Outperform” on Thursday, February 9. Maxim Group maintained the shares of PNRA in report on Thursday, September 29 with “Buy” rating. Wedbush maintained Panera Bread Co (NASDAQ:PNRA) on Thursday, April 28 with “Outperform” rating. The firm has “Hold” rating by Maxim Group given on Wednesday, August 19. Bernstein reinitiated the stock with “Outperform” rating in Thursday, May 26 report. The firm has “Outperform” rating by RBC Capital Markets given on Wednesday, July 20. The stock of Panera Bread Co (NASDAQ:PNRA) has “Buy” rating given on Thursday, January 19 by Goldman Sachs. On Tuesday, April 19 the stock rating was upgraded by Jefferies to “Buy”. The company was downgraded on Thursday, February 9 by Longbow. See Panera Bread Co (NASDAQ:PNRA) latest ratings:
10/02/2017 Broker: Telsey Advisory Group Rating: Outperform Old Target: $250 New Target: $270 Maintain
09/02/2017 Broker: Longbow Old Rating: Buy New Rating: Neutral Downgrade
09/02/2017 Broker: RBC Capital Markets Rating: Outperform Old Target: $250 New Target: $255 Maintain
19/01/2017 Broker: Goldman Sachs Old Rating: Neutral New Rating: Buy Upgrade
04/01/2017 Broker: Oppenheimer Old Rating: Perform New Rating: Outperform Upgrade
28/11/2016 Broker: Wedbush Old Rating: Outperform New Rating: Neutral Old Target: $220 New Target: $220 Downgrade
10/10/2016 Broker: Longbow Old Rating: Neutral New Rating: Buy Upgrade
29/09/2016 Broker: Maxim Group Rating: Buy Old Target: $230 New Target: $250 Maintain
The stock increased 1.07% or $2.44 on February 24, reaching $231.39. About shares traded. Panera Bread Co (NASDAQ:PNRA) has risen 10.21% since July 21, 2016 and is uptrending. It has outperformed by 0.87% the S&P500.
Panera Bread Company is a food service provider. The company has market cap of $5.43 billion. Panera is a national bakery-cafe concept with approximately 1,970 Company-owned and franchise-operated bakery-cafe locations in over 45 states, the District of Columbia, and Ontario, Canada. It has a 37.38 P/E ratio. The Firm operates through three divisions: Company Bakery-Cafe Operations, Franchise Operations, and Fresh Dough and Other Product Operations.
Since August 30, 2016, it had 0 insider buys, and 5 insider sales for $740,437 activity. Wooldridge Mark D. had sold 36 shares worth $7,897. On Friday, October 28 Blair Scott G sold $14,653 worth of Panera Bread Co (NASDAQ:PNRA) or 76 shares. 2,500 shares valued at $580,041 were sold by Moreton William W. on Friday, February 10. $95,884 worth of Panera Bread Co (NASDAQ:PNRA) was sold by LYNCH THOMAS E on Friday, December 2.
Investors sentiment decreased to 0.73 in Q3 2016. Its down 0.32, from 1.05 in 2016Q2. It fall, as 42 investors sold Panera Bread Co shares while 113 reduced holdings. 55 funds opened positions while 108 raised stakes. 21.37 million shares or 0.34% less from 21.44 million shares in 2016Q2 were reported. Advantus Management has 2,761 shares. California Public Employees Retirement accumulated 74,100 shares or 0.02% of the stock. Teachers Retirement Of The State Of Kentucky holds 0.01% of its portfolio in Panera Bread Co (NASDAQ:PNRA) for 6,000 shares. Kanaly Tru reported 0% in Panera Bread Co (NASDAQ:PNRA). 137 are owned by Blackrock Japan. Guggenheim Cap Limited Liability Company reported 23,478 shares. 225 are held by Bartlett Co Ltd. 24,476 are held by Segall Bryant Hamill Ltd. Pioneer Investment Mngmt invested 0.04% of its portfolio in Panera Bread Co (NASDAQ:PNRA). Farr Miller And Washington Limited Liability Com Dc stated it has 1,135 shares. Moreover, Texas Permanent School Fund has 0.04% invested in Panera Bread Co (NASDAQ:PNRA). Ls Advsr Limited Liability reported 0.02% in Panera Bread Co (NASDAQ:PNRA). State Of Tennessee Treasury Department accumulated 44,852 shares. Millennium Mgmt Ltd Llc reported 0.05% of its portfolio in Panera Bread Co (NASDAQ:PNRA). 2,000 were accumulated by Connable Office Inc.
Evgen Pharma plc is a clinical-stage drug development firm focused on cancer and neurological disease. The company has market cap of 17.68 million GBP. The Firm operates through the segment of development of pharmaceutical products all within the United Kingdom. It currently has negative earnings. The Company’s pipeline is based on its Sulforadex technology and includes various synthetic, stabilized analogues of the naturally occurring compound sulforaphane.
Among 2 analysts covering Evgen Pharma Plc (LON:EVG), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Evgen Pharma Plc has GBX 97 highest and GBX 79 lowest target. GBX 97’s average target is 303.83% above currents GBX 24.02 stock price. Evgen Pharma Plc had 27 analyst reports since October 26, 2015 according to SRatingsIntel. The company was maintained on Thursday, August 25 by Northland Capital. The firm has “Speculative Buy” rating by Beaufort Securities given on Tuesday, January 5. The rating was maintained by Northland Capital on Friday, January 13 with “Buy”. The rating was maintained by Northland Capital with “Buy” on Wednesday, August 17. The company was maintained on Wednesday, February 15 by Northland Capital. Beaufort Securities downgraded the shares of EVG in report on Thursday, August 18 to “Hold” rating. The stock of Evgen Pharma PLC (LON:EVG) earned “Speculative Buy” rating by Beaufort Securities on Wednesday, January 18. The stock has “Speculative Buy” rating by Beaufort Securities on Thursday, March 3. The firm has “Buy” rating given on Wednesday, December 2 by Northland Capital. The company was maintained on Thursday, September 15 by Northland Capital.
About 1,500 shares traded. Evgen Pharma PLC (LON:EVG) has risen 36.11% since July 28, 2016 and is uptrending. It has outperformed by 26.77% the S&P500.
Investors sentiment decreased to 0.44 in 2016 Q3. Its down 0.36, from 0.8 in 2016Q2. It turned negative, as 2 investors sold Evgen Pharma PLC shares while 18 reduced holdings. 6 funds opened positions while 10 raised stakes. 8.20 million shares or 3.69% less from 8.51 million shares in 2016Q2 were reported. Ladenburg Thalmann Services reported 0% in Evgen Pharma PLC (LON:EVG). 63,925 were accumulated by Hightower Advsr Ltd Co. Raymond James & Assoc invested in 17,767 shares. Wfg Advisors Limited Partnership holds 0.28% of its portfolio in Evgen Pharma PLC (LON:EVG) for 81,695 shares. Bancshares Of America Corp De has 49,245 shares for 0% of their portfolio. Invesco Ltd reported 327,017 shares. Sit Investment Associates holds 3.50M shares. Wells Fargo And Mn holds 0.01% of its portfolio in Evgen Pharma PLC (LON:EVG) for 1.24M shares. First Foundation Advsr holds 73,455 shares. Pnc Fincl Ser holds 0% or 22,845 shares in its portfolio. Guggenheim Capital Llc, a Illinois-based fund reported 40,741 shares. Credit Suisse Ag holds 0% in Evgen Pharma PLC (LON:EVG) or 26,028 shares. Sei Communications holds 0% or 66 shares in its portfolio. Cambridge Invest Rech Advsr Inc has 0.02% invested in Evgen Pharma PLC (LON:EVG). Rivernorth Mgmt Ltd, a Illinois-based fund reported 701,694 shares.
The post Evgen Pharma Plc (LON:EVG) Buy Rating Reaffirmed by Northland Capital; The Target Given is GBX 97.00, 15 Analysts Covering Panera Bread Co (PNRA) appeared first on Stock Market News | HillCountryTimes | Get it Today.
from
https://www.hillcountrytimes.com/2017/02/27/evgen-pharma-plc-lonevg-buy-rating-reaffirmed-by-northland-capital-the-target-given-is-gbx-97-00-15-analysts-covering-panera-bread-co-pnra/
No comments:
Post a Comment